Twist Bioscience Corp. Forecast, price target & analysts
Twist Bioscience Corp. Target price 2025 - Analyst rating & recommendation
Twist Bioscience Corp. Classifications & Recommendation:
Twist Bioscience Corp. Price Target
| Target Price | $40.80 |
| Price | $31.32 |
| Potential |
30.27%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Twist Bioscience Corp. 2026 .
The average Twist Bioscience Corp. target price is $40.80.
This is
30.27%
register free of charge
$60.03
91.66%
register free of charge
$35.35
12.87%
register free of charge
|
|
| A rating was issued by 16 analysts: 13 Analysts recommend Twist Bioscience Corp. to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Twist Bioscience Corp. stock has an average upside potential 2026 of
30.27%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2030
| Sep '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 312.97 | 382.11 |
| 27.69% | 22.09% | |
| EBITDA Margin | -46.16% | -24.87% |
| 34.10% | 46.12% | |
| Net Margin | -66.69% | -23.35% |
| 20.10% | 64.99% |
12 Analysts have issued a sales forecast Twist Bioscience Corp. 2025 . The average Twist Bioscience Corp. sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an Twist Bioscience Corp. EBITDA forecast 2025. The average Twist Bioscience Corp. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 Twist Bioscience Corp. Analysts have issued a net profit forecast 2025. The average Twist Bioscience Corp. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030
| Sep '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -3.60 | -1.48 |
| 0.00% | 58.89% | |
| P/E | negative | |
| EV/Sales | 4.29 |
12 Analysts have issued a Twist Bioscience Corp. forecast for earnings per share. The average Twist Bioscience Corp. EPS is
This results in the following potential growth metrics and future valuations:
Twist Bioscience Corp....
Current Twist Bioscience Corp. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Stephens & Co. |
Locked
➜
Locked
|
Locked | Nov 04 2025 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Oct 07 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Oct 02 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | May 06 2025 |
| Baird |
Locked
➜
Locked
|
Locked | May 06 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | May 06 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | May 06 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Stephens & Co.:
Locked
➜
Locked
|
Nov 04 2025 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Oct 07 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 02 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
May 06 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
May 06 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
May 06 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
May 06 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
